Microbes have made a phenomenal contribution to the health and well-being of people throughout the world. 1 Nowadays, drug discovery from microbial natural products has become more and more difficult. However, it is not the end of an era but an endless frontier. 2 To explore more bioactive compounds, a strain of Streptomyces avermitilis NEAU1069 that produced milbemycins was isolated from a soil sample. 3 Later, two novel macrolide compounds with a cyclohexyl group at the position of C-25, such as doramectin and avermectin B1a, were obtained from the fermentation broth, using bioactivity guided fractionation method, on adding cyclohexanecarboxylic acid to the fermentation medium. 4 The co-existence of milbemycins and avermectin implies that S. avermitilis NEAU1069 is an interesting strain and merits further study. Therefore, large amounts of fermentation broth (30 l) were collected and the detailed constituents were investigated; two other new compounds 1 and 2 ( Figure 1 ), similar to doramectin, were subsequently obtained. Here we describe the fermentation, isolation and structure elucidation of these two new doramectin analogs 1 and 2.
Compound 1 was obtained as a white amorphous powder. Its molecular formula was established to be C 44 H 68 O 11 as deduced from the high-resolution electron spray ionization (HRESI)-MS and 13 C NMR data ( Table 1) . The IR spectrum of 1 showed absorption bands assignable to the hydroxyl group (3447 cm À1 ) and an ester carbonyl (1705 cm À1 5 and doramectin 6 suggested that compound 1 was structurally related to doramectin and selamectin ( Figure 1 ). The differences between 1 and selamectin were in C-5, C-6, C-8 and C-23. The relative stereochemistry of 1 was assigned on the basis of the concurrence with those of doramectin and 25-cyclohexylavermectin B 2 . 6 To confirm the assignment of the sugar moiety of 1, acid hydrolysis of 1 was performed, and afforded an aglycone and a sugar. The sugar component was identified by TLC co-chromatography with the sugar obtained by acid hydrolysis of selamectin. The identical R F values of the two resulting sugars indicated that compound 1 and selamectin possessed the same sugar moiety.
Compound 2 was obtained as a white amorphous powder. Its molecular formula was established to be C 43 H 62 O 10 on the basis of HRESI-MS at m/z 761.4225 [M+Na] + (calculated as 761.4235 for C 43 H 62 NaO 10 ). The 1 H NMR spectrum of 2 displayed a methoxy group at d 3.52 and two downfield proton signals at d 6.62, 7.40. Its 13 C NMR spectrum showed 43 carbon resonances, including 7 methyls (1 oxygenated), 10 methylenes, 12 aliphatic methines (9 oxygenated), 12 sp 2 carbons, a ketal carbon and an ester carbonyl group. This suggested that 2 was also a doramectin derivative. Comparison of the 1 H and 13 C NMR data of 2 with those of 1, the differences between 2 and 1 were in C-2 to C-7 moiety in addition to the absence of a methoxy in 2. Further, comparing the 1 H and 13 C NMR data of C-2 to C-7 moiety of 2 with those of the same structural units in milbemycin b 3 , 7-9 b 4 , 10,11 b 13 , b 14 , 12 suggested that the C-2 to C-7 moiety in 2 was an aromatic ring as that of milbemycin b 3 , b 13 , b 14 . The HMBC correlations ( Figure 1c) 
confirmed the presence of a phenyl ring in 2. As a result, the gross structure of 2 was established as shown in Figure 1 . Biogenetically, the relative configuration of 2 was assigned as that of 1.
In conclusion, we obtained two new doramectin analogs from the culture broth of S. avermitilis NEAU1069. Along with previously obtained analogs of doramectin, avermectin and milbemycin from S. avermitilis NEAU1069, 3, 4 we believe that these two new compounds possibly have important roles in understanding and perfecting the proposed biosynthetic pathways of avermectins and milbemycins.
EXPERIMENTAL PROCEDURE General procedures and reagents
Melting points were measured using a Fisher-Johns micro-melting point apparatus (corrected; Fisher-Johns, Pittsburgh, PA, USA); UV spectra were obtained on a Varian CARY 300 BIO spectrophotometer (Varian, Palo Alto, CA, USA); IR spectra were recorded on a Nicolet Magna FT-IR 750 spectrometer (Nicolet Magna, Madison, WI, USA); 1 H-and 13 C-NMR spectra were measured using a Bruker DRX-400 (400 MHz for 1 H and 100MHz for 13 
Strain fermentation, isolation and purification of compounds
Details of the producing strain, S. avermitilis NEAU1069, were described in a previous paper. 3, 4 The strain was maintained on a YMS medium containing soluble starch (Bei Jing Ao Bo Xing, Beijing, China) 10 g, yeast extract (Bei Jing Ao Bo Xing) 2 g, KNO 3 Two new doramectin analogs from Streptomyces avermitilis X-J Wang et al of sterile water was added to the slant of the YMS medium. The spores were scraped and transferred onto a sterile tube containing glass beads; the spore suspension was then filtered through six layers of a sterile filter cheesecloth and adjusted to 10 7 -10 8 c.f.u. ml À1 . A 2.0 ml of the spore suspension was inoculated into a 250-ml flask containing 25 ml of seed medium and incubated at 28 1C for 24 h, shaken at 250 r.p.m. Then, 8.0 ml of the culture was transferred into 1-l Erlenmeyer flask containing 100 ml of the producing medium consisting of corn starch (Cormwin) 10%, soybean powder (Bei Jing Ao Bo Xing) 1%, cotton flour (Cormwin) 1%, a-amylase (Bei Jing Ao Bo Xing) 0.02%, NaCl 0.1%, K 2 HPO 4 0.2%, MgSO 4 7H 2 O 0.1%, CaCO 3 0.7%, cyclohexanecarboxylic acid 0.1%, pH 7.0, before sterilization. Fermentation was carried out at 28 1C for 12-13 days on a rotary shaker at 250 r.p.m. The fermentation broth (30 l) was filtered. The resulting cake was washed with water, and both filtrate and wash were discarded. Methanol (10 l) was used to extract the washed cake. The MeOH extract was evaporated under reduced pressure to approximately 2 l at 45 1C and the resulting concentrate was extracted three times using an equal volume of EtOAc. The combined EtOAc phase was concentrated under reduced pressure to yield 25 g of oily substances. The residual oily substance was chromatographed on silica gel and eluted with a petroleum ether-acetone mixture (95:5-50:50, v/v). The fractions eluted with the petroleum ether-acetone mixture (95:5-75:25, v/v) were combined and evaporated to obtain a crude mixture. The crude mixture was applied to a silica gel column and eluted with a petroleum ether-EtOAc mixture (95:5-50:50, v/v) to give five fractions (A1-A5). Fraction A3 eluted with a mixture of petroleum ether-EtOAc (75:25, v/v) was also subjected to silica gel eluting with a petroleum ether-EtOAc mixture (85:5-75:25, v/v) to give two subfractions B1 and B2.
Semipreparative HPLC (Agilent 1100, Zorbax SB-C18, 5 mm, 250Â9.4 mm i.d.) was used to obtain pure compounds. The eluate was monitored using a photodiode array detected at 220 nm, and the flow rate was 1.5 ml min À1 at room temperature. Subfraction B1 eluted with a mixture of petroleum etherEtOAc (75:25, v/v) was further separated by semipreparative HPLC using a solvent containing a CH 3 OH-H 2 O mixture (92:8, v/v) to obtain compound 1 (t R 24.2 min, 40 mg) and compound 2 (t R 21.5 min, 11 mg).
Physicochemical properties of 1 and 2
Compound 1 (Figure 1a) Acid hydrolysis of 1. Compound 1 (5.0 mg) was dissolved in 1 M HCl (1 ml) and then heated at 80 1C for 4 h. Aglycone was extracted with CHCl 3 three times, and the aqueous residue was evaporated under reduced pressure. The residue and the sugar obtained from selamectin, by the above procedure, were analyzed by TLC using chloroform-methanol (9:1, v/v) as a developing solvent. The spots were detected by spraying with anisaldehyde-H 2 SO 4 reagent followed by heating, and the result showed that the two sugars have the identical R F values (R F ¼0.6). 
